Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Annual Revenue ()

Innate Pharma revenue was €70.45 m in FY, 2020

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue€44.03 m€93.95 m€85.81 m€70.45 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Innate Pharma revenue breakdown by business segment: 15.0% from Government financing for research expenditures and 85.0% from Revenue from collaboration and licensing agreements

FY, 2017FY, 2018
Government financing for research expenditures€11.4 m€14.06 m
Revenue from collaboration and licensing agreements€32.63 m€79.89 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu